NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Norethindrone Acetate And Ethinyl Estradiol, and what generic alternatives are available?
Norethindrone Acetate And Ethinyl Estradiol is a drug marketed by Barr Labs Inc, Glenmark Pharms Ltd, Xiromed, Dr Reddys Labs Sa, Amneal Pharms, and Apotex. and is included in twenty-three NDAs.
The generic ingredient in NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL?
- What are the global sales for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL?
- What is Average Wholesale Price for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL?
Summary for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 23 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 5 |
| Clinical Trials: | 13 |
| Patent Applications: | 130 |
| DailyMed Link: | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL at DailyMed |
Recent Clinical Trials for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Virginia | Early Phase 1 |
| Ironwood Pharmaceuticals, Inc. | Phase 1 |
| National Institutes of Health (NIH) | Phase 3 |
See all NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL clinical trials
Pharmacology for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
| Drug Class | Estrogen Progestin |
| Mechanism of Action | Estrogen Receptor Agonists |
